VPM_logo for GBN.jpg
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
25 janv. 2023 04h00 HE | VPM - Vakzine Project Management GmbH
HANNOVER, Germany, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vakzine Projekt Management GmbH (VPM), a German drug development consultancy and service provider supporting small and medium pharma and biotech...
NRC logo.jpg
NRC Research Institute expands into Los Angeles
24 janv. 2023 09h30 HE | NRC Research Institute
LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- NRC Research Institute proudly announces the opening of the Center for Inclusion and Diversity in downtown Los Angeles. The Center for Inclusion and...
MCI
Male Contraceptive Initiative Invests in Eppin Pharma to Support Clinical Trials for a Non-Hormonal Male Contraceptive
19 janv. 2023 09h00 HE | Male Contraceptive Initiative
DURHAM, N.C., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Male Contraceptive Initiative (MCI), a 501(c)(3) non-profit, has partnered with the pharmaceutical company Eppin Pharma to provide a Program Related...
22157.jpg
Global Interactive Response Technology (IRT) Benchmarking & Market Dynamics 2022: Provider Selection Process, Outsourcing Trends, Provider Perceptions, Provider Performance, Company Profiles
17 janv. 2023 04h18 HE | Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "IRT Benchmarking & Market Dynamics (4th Ed)" report has been added to ResearchAndMarkets.com's offering.The Interactive Response Technology (IRT)...
North American Laboratory Animal Diets Market
North America Laboratory Animal Diets Market Report 2022: Growing Inclination Toward Customized Diet Plans for Laboratory Animals Presents Opportunities
17 janv. 2023 04h08 HE | Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "North America Laboratory Animal Diets Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Diet Type, Animal, Application, and End...
POINT logo light blue (png).png
POINT Biopharma Completes Randomization in PNT2002’s Phase 3 SPLASH Trial
12 janv. 2023 08h30 HE | POINT Biopharma
INDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to...
NVT Logo (4).jpg
Novotech Acquires European CRO – Strengthens Global Operations
12 janv. 2023 01h34 HE | Novotech
SINGAPORE, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...
22157.jpg
Global Phase I Market Outlook 2022-2026 - A High-Level View of the Phase I Clinical Development Space to Illustrate Current Market Dynamics and Inform Strategic Planning
10 janv. 2023 05h53 HE | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Phase I Market Outlook: 2022-2026" report has been added to ResearchAndMarkets.com's offering.The goal of this report is to provide readers with a...
NVT Logo (4).jpg
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug Development and FDA Regulatory Expertise
09 janv. 2023 11h34 HE | Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical...
NVT Logo (4).jpg
Novotech Acquires European CRO – Strengthens Global Operations
09 janv. 2023 11h33 HE | Novotech
SINGAPORE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...